sanford bernstein's nithya balasubramanian shares her views on biocon, gland pharma | cnbc-tv18
Published 1 year ago • 1.1K plays • Length 11:46Download video MP4
Download video MP3
Similar videos
-
6:56
biocon biologics restructures deal with sii | nithya balasubramanian speaks on this & more
-
7:57
sanford bernstein's nithya balasubramanian on q4 results of pharma cos & china opportunity
-
10:05
sanford bernstein's nithya balasubramanian's take on pharma universe | bazaar morning call
-
8:03
expect to see some traction in biocon in h2; like gland pharma among injectables: sanford bernstein
-
10:11
sanford bernstein's nithya balasubramanian's take on pharma stocks amid covid-19 concerns
-
7:50
bino pathiparampil shares views on gland pharma's q2fy23 results | halftime report | cnbc-tv18
-
6:59
cipla vs sun pharma - is pharma ready for a turnaround? | nithya balasubramanian, sanford bernstein
-
8:31
srinivas sadu of gland pharma speaks on acquiring 100% of cenext group | trading hour | cnbc-tv18
-
12:30
is pharma ripe for re-rating? | nithya balasubramanian of sanford bernstein to et now
-
3:27
srinivas sadu of gland pharma talks about the cenexi acquisition | halftime report | cnbc-tv18
-
12:02
will pharma stocks rally continue? nithya balasubramanian of bernstein | business news
-
6:49
what is in the covid portfolio of top pharma companies? | nithya balasubramanian to et now
-
0:52
d-street chatter: buzz about centrum capital, gland pharma & more | stocks to watch out for | n18s
-
14:26
nithya balasubramanian explains why pharma stocks are buzzing
-
1:22
sp tulsian on the future of sun pharma, biocon, aurobindo, nifty pharma & more | cnbc tv18
-
10:35
biocon's siddharth mittal speaks on selling stake in syngene & viatris biologics biz acquisition
-
1:33
q4fy24 results: clsa downgrades sun pharma to underperform; nomura neutral on gland pharma